Green Hygienics Holdings Inc. GRYN Company Overview

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2013 at 10:06 PM

Green Hygienics Holdings Inc. GRYN Company Overview

Stock Message Board http://investorshangout.com/search?q=GRYN&...mp;yt1=Go!

Green Hygienics Holdings Inc. GRYN Current Price and Quotes
Last Price 1.20
Previous Close 1.20 Open N/A
Daily Range N/A - N/A 52wk Range 2.29 - 1.02
Volume 0 Dividend N/A
Average Vol (3m) 2,286 Yield N/A
Green Hygienics Holdings Inc. GRYN
Company Information

1937 Pendrell Street
Suite 1004
Vancouver, BC V6G 1T4
Canada

Website: http://www.greenhygienicsholdings.com
Phone: 855-922-2368

Green Hygienics Holdings Inc. GRYN
Green Hygienics Holdings Inc. is a development stage company sourcing opportunities in the cleantech space.

Green Hygienics Holdings Inc. GRYN
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Apr 30, 2013 10-Q
CIK 0001443388
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 1000 - Metal Mining
Business Status Development Stage Company a/o Jun 25, 2013
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Dave Ashby President, Secretary, Treasurer
Company Directors

Not Available
Company Notes

Formerly=Takedown Entertainment Inc. until 7-2012
Formerly=Silver Bay Resources, Inc. until 6-2010
Service Providers

Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States

Legal Counsel
MacDonald Tuskey Corp.
400 - 570 Granville Street
Vancouver, BC, V6C 3P1
Canada

Investor Relations Firm
Not Available

Green Hygienics Holdings Inc. GRYN
GRYN Security Details

Share Structure

Market Value1 $11,157,976 a/o Sep 20, 2013
Shares Outstanding 9,298,313 a/o Jun 10, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 18 a/o Nov 30, 2012
Security Notes

Capital Change=shs increased by 5 for 1 split, payable upon surrender. Pay date=06/30/2010.
Capital Change=shs decreased by 1 for 2000 split. Pay date=07/24/2012.
Short Selling Data

Short Interest 2 (100%)
Jul 31, 2012
Significant Failures to Deliver No
Transfer Agent(s)

Empire Stock Transfer Inc.

Green Hygienics Holdings Inc. GRYN Recent News

Sept 17, 2013 Green Hygienics Holdings Inc. Welcomes Claudio Fontenelle Angelim, Renata Mourao and Wilmar Pereira to the Company
Sept 10, 2013 Green Hygienics Holdings Inc. Team Returns From Brazil
Sept 7, 2013 Green Hygienics Holdings Inc. Welcomes Don Hicks and David Harris to the Company
Jul 8, 2013 Green Hygienics Holdings Inc. Provides Shareholders And Investors With An Executive Update On Corporate Development

Green Hygienics Holdings Inc. GRYN Financials
Period Ending Jul 31, 2012 Jul 31, 2011 Jul 31, 2010 Jul 31, 2009
Total Revenue 75 75 - -
Cost of Revenue - - - -
Gross Profit 75 75 - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,207 859 49 28
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,132) (784) (49) (34)
Income From Continuing Operations

Add'l Income/Expense Items (101) - - -
Earnings Before Interest and Tax (1,234) (784) (55) (34)
Interest Expense 4 46 - 7
Earnings Before Tax (1,238) (830) (55) (41)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,238) (830) (55) (41)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,238) (830) (55) (34)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,238) (830) (55) (34)

GRYN Green Hygienics Holdings Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GRYN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GRYN/quote
Stock Chart http://www.otcmarkets.com/stock/GRYN/chart
Company Info http://www.otcmarkets.com/stock/GRYN/company-info
Recent News http://www.otcmarkets.com/stock/GRYN/news
Financials http://www.otcmarkets.com/stock/GRYN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GRYN/filings
Short Sales http://www.otcmarkets.com/stock/GRYN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GRYN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GRYN/research
Summary http://finance.yahoo.com/q?s=GRYN
Historical Prices http://finance.yahoo.com/q/hp?s=GRYN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GRYN
Basic Chart http://finance.yahoo.com/q/bc?s=GRYN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GRYN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GRYN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GRYN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GRYN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GRYN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GRYN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GRYN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GRYN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GRYN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GRYN
Balance Sheet http://finance.yahoo.com/q/bs?s=GRYN
Cash Flow http://finance.yahoo.com/q/cf?s=GRYN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GRYN
Market Watch http://www.marketwatch.com/investing/stock/GRYN
Bloomberg http://www.bloomberg.com/quote/GRYN:US
Morningstar http://quotes.morningstar.com/stock/s?t=GRYN
Bussinessweek http://investing.businessweek.com/research/st...icker=GRYN
Barchart http://www.barchart.com/quotes/stocks/GRYN
OTC Short Report http://otcshortreport.com/index.php?index=GRYN
Investopedia http://www.investopedia.com/markets/stocks/GRYN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...